SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

By | April 30, 2022
A new study describes the development of new molecules with inhibitory activity against the SARS-CoV-2 viral main protease (Mpro) enzyme, based on rattlesnake venom.